Action DRREDDY DR. REDDY'S LABORATORIES LIMITED
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Dr. Reddy's Laboratories Limited

Actions

DRREDDY

INE089A01023

Temps Différé Bombay S.E.
Autres places de cotation
 09:03:35 07/06/2024 		Varia. 5j. Varia. 1 janv.
6 034 INR +2,32 % Graphique intraday de Dr. Reddy's Laboratories Limited +4,47 % +4,28 %
04/06 Dr. Reddy's Arm ouvre un site de production de produits biologiques à Hyderabad, en Inde MT
31/05 Les actions asiatiques négociées aux États-Unis sous forme de certificats de dépôt américains sont en baisse vendredi matin MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Dr Reddy Laboratories : Surveillance of ICRA assigned Credit Rating for Rs. 500.00 crore Bank Facilities and Enhancement of Rs. 700.00 Crores Bank Facilities of Dr. Reddy's Laboratories Limited Form 6 K
Dr. Reddy's Arm Opens Biologics Facility in Hyderabad, India
Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading
India's pharma export sales to grow faster this year, trade body says
Asian Equities Traded in the US as American Depositary Receipts Open Week Slightly Lower in Tuesday Trading
Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America
Dr. Reddy's Laboratories Limited Announces Appointment of Milan Kalawadia as Chief Executive Officer, North America
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research
Dr. Reddy's Laboratories LLC, Russia Enters into Distribution Agreement with Novartis Pharma LLC
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Lower
Reddy Pharma Iberia y Theranica lanzan Nerivio® en España ofreciendo a los pacientes que padecen migraña un tratamiento no farmacológico
Dr. Reddy's Laboratories Limited Informed That the Company Has Received an Order from GST Authority Towards Tax Demand Including Interest and Penalty
Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading
Indian shares set to rise at open; Fed minutes eyed
Asian Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK
Alvotech and Dr. Reddy's Partner to Commercialize Biosimilar Candidate Denosumab
Asian Equities Traded in the US as American Depositary Receipts Open Week Higher
Asian Equities Traded in the US as American Depositary Receipts Ease in Thursday Trading
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action DRREDDY
  4. Actualités Dr. Reddy's Laboratories Limited
  5. Autres langues